CM

Catherine Mohr

Aroa Biosurgery Limited | Non-Executive Director
Dr Mohr has over 30 years' experience across fields, including engineering, healthcare, alternative energy, aerospace and global entrepreneurship. Her expertise spans many areas related to AROA's next stage of growth, including medtech product research and development, FDA approvals, product commercialisation and surgery technology innovation. She has been President of the Intuitive Foundation since 2018. Prior to leading the Foundation, Catherine held senior roles at Intuitive Surgical, including Vice President of Strategy and Director of Medical Research. Intuitive Surgical is a pioneer in the robotic-assisted surgery field and developed the da Vinci surgical robotic system which is used in millions of surgical procedures across the globe every year. Catherine is also on the board of directors for FINCA International and cofounded VeriSure, where she invented the LapCap, the first of a new category of laparoscopic surgery enabling products. She is member of the Risk Committee.

Company and Role

Company
Title
Tenure
Since
ARX
Aroa Biosurgery Limited
  • Non-Executive Director
2yrs, 5mthNov 2022

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
ARX
Aroa Biosurgery Limited
30/09/240436,364210,686N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
ARX
Aroa Biosurgery Limited
30/09/24
Buy
436,364$0.375$163,453On-market trade
ARX
Aroa Biosurgery Limited
11/08/23
Issued
210,686$0.880$185,403Issue of options